6S Pharma Solutions Profile
Key Indicators
- Authorised Capital ₹ 3.30 Cr
- Paid Up Capital ₹ 3.05 Cr
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -91.66%
- Profit Growth -67.28%
- Ebitda -9.45%
- Net Worth 0.25%
- Total Assets -0.27%
About 6S Pharma Solutions
6S Pharma Solutions Private Limited (6PSPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 March 2018 (Six years and 11 months 5 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.30 Cr and a paid-up capital of Rs 3.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jagadeeshwar Prodduturi, Prodduturi Reddy, Illapakurthy Amrutha, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24304TG2018PTC123174
- Company No.
123174
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 2018
- Date of AGM
31 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at 6S Pharma Solutions?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagadeeshwar Prodduturi  | Director | 09-Nov-2019 | Current |
| Prodduturi Reddy | Director | 21-Mar-2018 | Current |
| Illapakurthy Amrutha | Director | 21-Mar-2018 | Current |
| Ashok Illapakurthy | Director | 14-Jul-2018 | Current |
Financial Performance of 6S Pharma Solutions.
6S Pharma Solutions Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 91.66% decrease. The company also saw a substantial fall in profitability, with a 67.28% decrease in profit. The company's net worth moved up by a moderate rise of 0.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of 6S Pharma Solutions?
Unlock access to 6S Pharma Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sri Kpr Industries LimitedJagadeeshwar Prodduturi is a mutual person
- Sri Kpr Infra & Projects Limited
Jagadeeshwar Prodduturi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at 6S Pharma Solutions?
Unlock and access historical data on people associated with 6S Pharma Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of 6S Pharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped 6S Pharma Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.